Acorda Therapeutics To Present At The 9th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference

HAWTHORNE, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics (Nasdaq:ACOR) today announced that Ron Cohen, President and CEO, will present at the upcoming 9th Annual BIO CEO & Investor Conference on Monday, February 12th at 11:45 am Eastern Standard Time (EST).

MORE ON THIS TOPIC